Morgan Stanley Haemonetics Corp Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Haemonetics Corp stock. As of the latest transaction made, Morgan Stanley holds 483,969 shares of HAE stock, worth $41.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

483,969

Previous 417,006 16.06%

Holding current value

$41.4 Million

Previous $34.5 Million 12.75%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$72.45 - $91.58 $4.85 Million - $6.13 Million	66,963 Added 16.06%	483,969 $38.9 Million
Q2 2024 Oct 17, 2024	BUY	$81.24 - $97.37 $8.46 Million - $10.1 Million	104,128 Added 33.28%	417,006 $34.5 Million
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $8.46 Million - $10.1 Million	104,128 Added 33.28%	417,006 $34.5 Million
Q1 2024 Oct 17, 2024	SELL	$71.24 - $85.35 $7.42 Million - $8.89 Million	-104,128 Reduced 24.97%	312,878 $26.7 Million
Q1 2024 Aug 16, 2024	SELL	$71.24 - $85.35 $9.05 Million - $10.8 Million	-127,005 Reduced 28.87%	312,878 $26.7 Million
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $9.05 Million - $10.8 Million	-127,005 Reduced 28.87%	312,878 $26.7 Million
Q4 2023 Aug 16, 2024	BUY	$80.59 - $92.61 $1.84 Million - $2.12 Million	22,877 Added 5.49%	439,883 $37.6 Million
Q4 2023 Feb 13, 2024	SELL	$80.59 - $92.61 $5.2 Million - $5.98 Million	-64,520 Reduced 12.79%	439,883 $37.6 Million
Q3 2023 Nov 15, 2023	SELL	$82.56 - $93.49 $968,346 - $1.1 Million	-11,729 Reduced 2.27%	504,403 $45.2 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $21.9 Million - $24.2 Million	270,534 Added 110.15%	516,132 $43.9 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $342,361 - $426,363	4,706 Added 1.95%	245,598 $20.3 Million
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $8.52 Million - $9.94 Million	-115,360 Reduced 32.38%	240,892 $18.9 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $813,594 - $1.01 Million	-12,853 Reduced 3.48%	356,252 $26.4 Million
Q2 2022 Oct 27, 2022	SELL	$49.27 - $66.08 $3.59 Million - $4.81 Million	-72,850 Reduced 16.48%	369,105 $24.1 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $3.59 Million - $4.81 Million	-72,850 Reduced 16.48%	369,105 $24.1 Million
Q1 2022 Oct 27, 2022	BUY	$43.77 - $63.22 $3.19 Million - $4.61 Million	72,850 Added 19.74%	441,955 $27.9 Million
Q1 2022 May 13, 2022	BUY	$43.77 - $63.22 $136,343 - $196,930	3,115 Added 0.71%	441,955 $27.9 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $12.1 Million - $18.2 Million	243,484 Added 124.64%	438,840 $23.3 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $11.3 Million - $13.8 Million	195,356 New	195,356 $13.8 Million

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account